Animal Antibiotics and Antimicrobials Market Share
The animal antibiotics and antimicrobials market consists of several players including:
Zoetis Inc.
Merck & Co., Inc.
Elanco Animal Health Incorporated
Boehringer Ingelheim International GmbH
Ceva Sante Animal
Virbac
Vetoquinol
Bayer AG
Novartis AG
Eli Lilly
Sanofi
Arthrex
to maintain a competitive edge in the industry.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
Global market for animal antibiotics & antimicrobials was valued at over USD 4.6 billion in 2022 and is forecasted to reach over USD 6.7 billion by 2032.
The tetracyclines segment accounted for over 42.6% share of the animal antibiotics and antimicrobials market in 2022 and is expected to record robust demand due to its highest potency against pathogenic microorganisms.
The livestock animals segment held a 57.9% market share in 2022 and is projected to expand further driven by rising demand for animal-based products & the introduction of regulations to prevent diseases.
Zoetis Inc., Merck & Co., Inc., Boehringer Ingelheim International GmbH, Virbac, Vetoquinol, Bayer AG, Novartis AG, Eli Lilly, and Sanofi are some of the leading players in the animal antibiotics and antimicrobials market.
Animal Antibiotics and Antimicrobials Market Scope